Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01489514 · ClinicalTrials.gov registry record
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 22
- Enrollment target
NCT01489514: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT01489514 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01489514 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
This is a proof of concept study to determine the safety and allergenicity of hypoallergenic peanut product extract as compared to standard peanut extract in an adult population with known peanut allergy. This will be assessed by epicutaneous skin prick testing. The hypothesis is that subjects with previously diagnosed peanut allergy will have less epicutaneous reactions to the hypoallergenic peanut product extract.
Primary Outcome
Size of wheal for hypoallergenic extracts will be measured.
Interventions
- OTHER Epicutaneous skin prick testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-01 |
What the finished NCT01489514 record still lists
NCT01489514 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Epicutaneous skin prick testing is the first listed.
NCT01489514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01489514 about?
NCT01489514 is a clinical study titled "Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects". This is a proof of concept study to determine the safety and allergenicity of hypoallergenic peanut product extract as compared to standard peanut extract in an adult population with known peanut allergy. This will be assessed by epicutaneous skin prick testing. The hypothesis is that subjects with ...
What is the current status of trial NCT01489514?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2011-12. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01489514?
The interventions under investigation include: Epicutaneous skin prick testing (OTHER).
Who is sponsoring clinical trial NCT01489514?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia